These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18025240)

  • 1. Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2.
    Hombach AA; Kofler D; Hombach A; Rappl G; Abken H
    J Immunol; 2007 Dec; 179(11):7924-31. PubMed ID: 18025240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
    Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
    J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts.
    Yashiro-Ohtani Y; Zhou XY; Toyo-Oka K; Tai XG; Park CS; Hamaoka T; Abe R; Miyake K; Fujiwara H
    J Immunol; 2000 Feb; 164(3):1251-9. PubMed ID: 10640738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.
    Colombetti S; Basso V; Mueller DL; Mondino A
    J Immunol; 2006 Mar; 176(5):2730-8. PubMed ID: 16493028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.
    Hilchey SP; De A; Rimsza LM; Bankert RB; Bernstein SH
    J Immunol; 2007 Apr; 178(7):4051-61. PubMed ID: 17371959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
    Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
    J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells.
    He X; Smeets RL; van Rijssen E; Boots AM; Joosten I; Koenen HJ
    Sci Rep; 2017 Feb; 7():43003. PubMed ID: 28223693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LFA-1-mediated costimulation of CD8+ T cell proliferation requires phosphatidylinositol 3-kinase activity.
    Ni HT; Deeths MJ; Mescher MF
    J Immunol; 2001 Jun; 166(11):6523-9. PubMed ID: 11359803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells.
    Valenzuela J; Schmidt C; Mescher M
    J Immunol; 2002 Dec; 169(12):6842-9. PubMed ID: 12471116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.
    Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H
    J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
    Masuyama J; Kaga S; Kano S; Minota S
    J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
    Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
    J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
    Finney HM; Akbar AN; Lawson AD
    J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3.
    Owaki T; Asakawa M; Kamiya S; Takeda K; Fukai F; Mizuguchi J; Yoshimoto T
    J Immunol; 2006 Mar; 176(5):2773-80. PubMed ID: 16493033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 costimulation Impairs the efficacy of a redirected t-cell antitumor attack in the presence of regulatory t cells which can be overcome by preventing Lck activation.
    Kofler DM; Chmielewski M; Rappl G; Hombach A; Riet T; Schmidt A; Hombach AA; Wendtner CM; Abken H
    Mol Ther; 2011 Apr; 19(4):760-7. PubMed ID: 21326215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.